PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
PPP1R14D | Protein phosphatase 1, regulatory (inhibitor) subunit 14D | | | | | | Group enriched |
REG4 | Regenerating islet-derived family, member 4 | Predicted secreted proteins
| | | | | Group enriched |
RP11-595B24.2 | Uncharacterized protein | | | | | | Group enriched |
SATB2 | SATB homeobox 2 | Disease related genes Transcription factors
| | | | | Group enriched |
SHD | Src homology 2 domain containing transforming protein D | | | | | | Group enriched |
SULT1A2 | Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | Enzymes
| | | | | Group enriched |
USH1C | Usher syndrome 1C (autosomal recessive, severe) | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
XDH | Xanthine dehydrogenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
AC011897.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC138517.1 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGR2 | Anterior gradient 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
ATP10B | ATPase, class V, type 10B | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ATP2C2 | ATPase, Ca++ transporting, type 2C, member 2 | Enzymes Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
B3GALT1 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT6 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase) | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT2 | Beta-1,4-N-acetyl-galactosaminyl transferase 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
BCL2L14 | BCL2-like 14 (apoptosis facilitator) | | | | | | Tissue enhanced |
C15orf48 | Chromosome 15 open reading frame 48 | | | | | | Tissue enhanced |
C9orf152 | Chromosome 9 open reading frame 152 | | | | | | Tissue enhanced |
CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA7 | Carbonic anhydrase VII | Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
CAPN9 | Calpain 9 | Enzymes
| | | | | Tissue enhanced |
CCL1 | Chemokine (C-C motif) ligand 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL15 | Chemokine (C-C motif) ligand 15 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL24 | Chemokine (C-C motif) ligand 24 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL26 | Chemokine (C-C motif) ligand 26 | Predicted secreted proteins
| | | | | Tissue enhanced |
CEA | Uncharacterized protein | Predicted secreted proteins
| | | | | Tissue enhanced |
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CES3 | Carboxylesterase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN8 | Claudin 8 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CPA6 | Carboxypeptidase A6 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CTD-3214H19.4 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
FAM3D | Family with sequence similarity 3, member D | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FERMT1 | Fermitin family member 1 | Disease related genes
| | | | | Tissue enhanced |
FOXD2 | Forkhead box D2 | Transcription factors
| | | | | Tissue enhanced |
FRMD1 | FERM domain containing 1 | Cytoskeleton related proteins
| | | | | Tissue enhanced |
FXYD3 | FXYD domain containing ion transport regulator 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GALNT5 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) | Enzymes
| | | | | Tissue enhanced |
GALNT8 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GCNT3 | Glucosaminyl (N-acetyl) transferase 3, mucin type | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
GPR15 | G protein-coupled receptor 15 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPX2 | Glutathione peroxidase 2 (gastrointestinal) | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
HAVCR1 | Hepatitis A virus cellular receptor 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HEPACAM2 | HEPACAM family member 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
HOXB9 | Homeobox B9 | Transcription factors
| | | | | Tissue enhanced |